ARCHIVES

Low Prevalence Of Tamoxifen Use For Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 33 No. 2 | February 26, 2010

Download PDF Visit The Full Archive

Related Articles

Nexavar Improves PFS In Phase III Trial

January 25, 2013

Cancer Leadership Council letter calls for permanent leadership of NCI and FDA.

November 23, 2005

Investigator Initiated Clinical Research Gets More For Less Money, Carbone Contends

April 13, 1979

Clinical Trials Approved By NCI Listed For September

September 24, 2004

In Brief: Healy to Name Jay Moskowitz Deputy Direct, Promote Mahoney To Deputy Budge Director

March 6, 1992

ACS Awards Professorships To Brugge, Hanahan, Samson; Renews Verma, Wigler.

February 9, 2001